Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
iGATE Research has released a research report on “Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025” Click here to view the complete report: www.igateresearch.com Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
According to MRFR Analysis – blood testing market research is expected to accrue strong growth in forecast period 2017 to 2023. The global market research report provides in-depth industry analysis with free additional customization, including the impact of the COVID-19 pandemic.
Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
The report on In-vitro Diagnostics Instruments Market by product (immunochemistry, clinical microbiology, POCT, tissue diagnostics, molecular diagnostics, hematology, hemostasis, SMBG), end user(hospitals and diagnostic laboratories, research institutes) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global In-vitro Diagnostics Instruments Market is projected to grow at a CAGR of 9.3% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
Vitamin D Testing can be divided into five categories: RIA type, ELISA type, CLIA type, POCT type and LC-MS/MS type. CLIA type account for the highest proportion in the revenue market, with a figure of 72.11% in 2017, followed by ELISA type account for 9.37%.
Point-of-care Cholesterol Monitoring Device Market: Inclination Towards Portable Devices & Increasing Cholesterol Home Testing Trending the Global Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
The global in-vitro diagnostics market was valued at around $56 billion in 2017. The USA was the largest country in the market in 2017, accounting for under 21% market share. Read More: https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-market-global-briefing-2018
Point-of-care coagulation testing devices market is projected to expand at a CAGR of ~6% during the forecast period, leading players in the market focus on new products with multiple modes and features, which will be more efficient and deliver a new level.
This TriMark Publications report “Point of Care Diagnostic Testing World Markets” describes latest developments in the point of care testing market segment. For more details : http://goo.gl/6pZ2p8
Global Biosensors Development & Demand Market, by Application (Medical Testing, Food Toxicity, Industrial Process),by Technology (Electrochemical Biosensors, Optical Biosensors, Thermal Biosensors), by End Users (Research Laboratories, Home Diagnostics, Food Industry) - Global Forecast 2027
Complete report on In-Vitro Diagnostics (IVD) market spread across 81 pages providing 4 company profiles and 3 tables and 48 charts is now available at http://www.marketreportsonline.com/547317.html.
NON-FUNCTIONAL REQUIREMENTS MATTIAS ARMHOLT ERICSSON AB Agenda Introduction Model Design Techniques Conclusions Model Based Test Design for Performance Testing and ...
Europe POCT Device Market is expected to reach USD 11,682.54 billion by 2024 from USD 6,051.05 billion in 2016, at a CAGR of 8.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Global Point of Care Technology Market Information by Product Type (Glucose Testing, Cardiac Markers, Hb1Ac Testing, Coagulation), by Instrument (Blood Glucose Meter), by End User (Clinics, Hospital, Home Care, Ambulatory Care) - Forecast to 2027
Access full Research: https://www.renub.com/point-of-care-testing-market-and-forecast-to-2016-global-analysis-158-p.php Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024 experiencing a significant growth over the forecast period. The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry.
[452 Pages Report] Point-Of-Care Diagnostics / Testing Market report categories the Global market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
China In Vitro Diagnostics Market will be USD 22.3 Billion by 2026. Forecast by Segment (Clinical Chemistry, Immunoassay, Molecular Testing, Microbiology, Hematology, SMBG, Point of Care Testing, Coagulation), Company Analysis.
According to Renub Research market research report "Saudi Arabia In Vitro Diagnostics (IVD) Market, by Techniques (Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, SMBG, POCT), Applications (Infectious, Cardiovascular Diseases), End User, Companies" Saudi Arabia In Vitro Diagnostics Market is forecasted to reach US$ 700 Million by the year 2024.
GLOBAL SERVICES Lesson 3: Innovation in the Service Sector INNOVATION DEFINED Innovation: the implementation of a new or significantly improved product (good or ...
A recent report published by TheBusinessResearchCompany on Point-of-Care Diagnostics Devices And Equipment Market provides in-depth analysis of segments and sub-segments in the global as well as regional. http://bit.ly/2SsaM53
In-Vitro Diagnostic tests provide adequate information about the diseases without interacting directly to the human body. Saudi Arabia IVD Market is poised to reach US$ 700 Million by the year 2024. Renub Research report titled “Saudi Arabia In Vitro Diagnostics (IVD) Market, by Techniques, by Applications, by End User and by Companies (Roche, Abbott, Siemens Healthineers, Sysmex Corporation and Danaher Corporation)” provides a complete analysis of Saudi Arabia In-Vitro Diagnostics (IVD) Market. Access full Research: https://www.renub.com/saudi-arabia-in-vitro-diagnostics-market-p.php
Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive.
The rising incidence of chronic diseases, like diabetes, rheumatism, or cancer is increasing steadily worldwide due to poor lifestyle choices and increasing obesity, thus driving the growth of POC devices and equipment market.
For more Info: https://www.renub.com/point-of-care-testing-market-nd.php Point of care testing (POCT), also known as bedside testing is a medical diagnostic testing that allows patient diagnoses on the field, in the ambulance, at the physician’s office, in the hospital, or at home. The results of the point of care testing are timely and accurate which allow rapid treatment to the patient. Point of care testing has the potential to widely impact the health care delivery system by addressing the challenges of health disparities in real time. The success of the potential shift from remedial medicine to modified, prognostic and preventive medicine could rely on the enhancement of portable monitoring and diagnostic devices for point of care testing. Point of Care Testing Market is projected to reach US$ 36 Billion by the end of year 2024.
IVD tests help diagnose, monitor, and assess medical conditions, diseases, and infections in a controlled environment. These tests help in early diagnosis of diseases by enhancing control on test procedures and provide accurate results, leading to quality treatment and shorter hospital stays.
iGATE RESEARCH report titled “China IVD Market and Forecast to 2020” is a 86 page report with 34 Figures and 1 Table. This report studies in details the China IVD Market - Application Segment Wise, China IVD Market - Company Sales, Development Environment and Regulatory Status in China IVD market and Driving Factors and Challenges for China IVD Market. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=China%20IVD%20Market%20and%20Forecast%20to%202020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com
of animal testing: emerging ... carcinogenic tests ld 50 toxicity test banned * kishore ... plastinated specimens development of alternatives to use of animals in ...
iGATE RESEARCH report titled “China IVD Market and Forecast to 2020” is a 86 page report with 34 Figures and 1 Table. This report studies in details the China IVD Market - Application Segment Wise, China IVD Market - Company Sales, Development Environment and Regulatory Status in China IVD market and Driving Factors and Challenges for China IVD Market. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=China%20IVD%20Market%20and%20Forecast%20to%202020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com
Blood Gas and Electrolyte Analyzers Market Size by Product, By Application, By End-User, Industry Analysis Report, Regional Outlook, Application Potential, Price Trend, Competitive Market Share & Forecast, 2016 - 2023
infectious disease detection Keith Perry PhD Head, Microbiological Diagnostics Assessment Service (HPA-MiDAS) BSMT, 8th May 2009 PoCT background Past Present PoCTs ...
The global In-vitro diagnostics (IVD) market is estimated to reach USD 80 Billion, in 2024. In 2014, India holds total 1% market share of global IVD market. To get more details read our report: https://bit.ly/2fD38Do
The emerging healthcare industry represents more than USD1.3 trillion and is growing at the rate of 6.8% across the globe. Out of which global medical device market in the year 2016 reached USD315 billion on the back of rapid advancement in medical devices technology
Point-of-Care Diagnostics Market Global Briefing 2017 provides the strategists, marketers and senior management with the critical information they need to assess the global point-of-care diagnostics market. The global point-of-care diagnostics market was estimated to be around $20.2 billion as of 2016. The global point-of-care diagnostics made up around 34% of the overall in-vitro diagnostics market in 2016. Complete Report available at: http://www.rnrmarketresearch.com/point-of-care-diagnostics-market-global-briefing-2017-including-glucose-and-cardiometabolic-monitoring-kits-infectious-diseases-testing-kits-cardiac-and-cancer-markers-covering-alere-abbott-diagnostics-siemen-biomerieux-market-report.html
It highlights the competitive outlook of major global players that includes the business strategies, product portfolio, revenue distribution, financial analysis, R&D activities and investments. The in-depth analysis of facility management market report will help the clients to assess their business strategies as per the competitive environment in the market space.
Overall, the report represents the Global Military Communication Market trends along with a market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.
Experiencing Globalization How Sushi Went Global, (Bestor) and McDonald s in Hong Kong (Watson) Consumerism consumerism is a social and economic order ...
China In-vitro diagnostics market is expected to be triple its market size by the end of 2022 from its market size in 2016. China In-Vitro Diagnostics sector is expected to grow with a double digit CAGR of 19.01% in future. With such a huge growth rate China is poised to become the world’s largest In–vitro Diagnostics (IVD) Market in the next few years for both domestic and foreign IVD products. The In–Vitro Diagnostics (IVD) Market in China has been growing rapidly over the past few years and is expected to grow steadily in the coming future, with major growth potential in segments such as contagious disease testing, chronic disease testing and diagnosis in early stages of disease. Download Full Report: http://www.renub.com/china-in-vitro-diagnostics-ivd-market-forecast-companies-analysis-registration-rules-1089-p.php
Title: Debating Globalization Author: Nic Last modified by: Nic Created Date: 9/2/2010 4:37:17 PM Document presentation format: On-screen Show Other titles
Marketing Management Lecture Lesson By Chinmay Das Syllabus Module I (10 hours) Marketing Management: Concept, Process, Functions and relevance in the current ...
Access full Research: https://www.renub.com/china-in-vitro-diagnostics-ivd-market-forecast-companies-analysis-registration-rules-1089-p.php China IVD Market is projected to exceed US$ 12 Billion by the end of year 2024. China IVD Market is growing significantly and is expected to continue its ongoing trend during the forecast period as well, owing to rapidly increasing middle class population who is now willing to pay more for better healthcare services and aging population who are more vulnerable to contagious diseases. Also, Chinese aging population is experiencing an outburst of chronic diseases which includes cancer, diabetes and cardiovascular disease. All of these diseases can be diagnosed and monitored using IVD products.
For more Info: https://www.renub.com/china-in-vitro-diagnostics-market-is-expected-to-grow-with-19-cagr-by-2022-32-nd.php The report China IVD Market, by Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT)], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)” provides a complete analysis of China In–Vitro Diagnostics (IVD) Market. The market for China In-Vitro Diagnostics (IVD) is likely to exceed US$ 12 Billion by the end of year 2024. Request a free sample copy of the report: https://www.renub.com/contactus.php